Summary
This Form 8-K filing from Boston Scientific Corporation (BSX) reports on the outcomes of its 2013 Annual Meeting of Stockholders, held on May 7, 2013. The primary focus of the report is the voting results on key matters presented to shareholders. Investors will be interested to note the election of all director nominees for the upcoming year, as well as the advisory approval of executive compensation. The company also successfully ratified the appointment of its independent auditor, Ernst & Young LLP, for the fiscal year 2013. These results indicate shareholder confidence in the current board and management's compensation practices, as well as continued trust in the company's financial oversight. The overwhelming majority of votes cast in favor of these proposals suggest stability and shareholder alignment with the company's governance and financial reporting.
Key Highlights
- 1All director nominees presented at the 2013 Annual Meeting of Stockholders were elected to the Board for a one-year term.
- 2The advisory vote to approve the compensation of Named Executive Officers received majority shareholder approval.
- 3Ernst & Young LLP was ratified as the company's independent registered public accounting firm for the fiscal year 2013.
- 4The Annual Meeting of Stockholders took place on May 7, 2013, at the company's Corporate Headquarters in Natick, Massachusetts.
- 5Broker non-votes represented a significant portion of the shares in the director elections and executive compensation vote, indicating a substantial number of shares held by brokers not voted on these specific matters.
- 6The vote for Ernest Mario, a director nominee, received a notably lower number of 'For' votes compared to other nominees, though still passed.